Advanced Proteome Therapeutics Corp (APTCF)
0.0002
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Advanced Proteome Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| July 31, 2011 | 0.00 |
| April 30, 2011 | 0.00 |
| January 31, 2011 | 0.00 |
| October 31, 2010 | 0.00 |
| July 31, 2010 | 0.00 |
| April 30, 2010 | 0.00 |
| January 31, 2010 | 0.00 |
| October 31, 2009 | 0.00 |
| July 31, 2009 | 0.00 |
| April 30, 2009 | 0.00 |
| January 31, 2009 | 0.00 |
| October 31, 2008 | 0.00 |
| July 31, 2008 | 0.00 |
| April 30, 2008 | 0.00 |
| January 31, 2008 | 0.00 |
| October 31, 2007 | 0.00 |
| July 31, 2007 | 0.00 |
| April 30, 2007 | 0.00 |
| January 31, 2007 | 0.0714 |
| October 31, 2006 | 0.00 |
| July 31, 2006 | 0.00 |
| April 30, 2006 | 0.00 |
| January 31, 2006 | 0.00 |
| October 31, 2005 | 0.00 |
| July 31, 2005 | 1.018 |
| Date | Value |
|---|---|
| April 30, 2005 | -0.9615 |
| January 31, 2005 | -0.9778 |
| October 31, 2004 | -1.034 |
| July 31, 2004 | -1.059 |
| April 30, 2004 | -0.9999 |
| January 31, 2004 | -1.016 |
| October 31, 2003 | -1.081 |
| July 31, 2003 | -1.179 |
| April 30, 2003 | -1.131 |
| January 31, 2003 | -1.237 |
| October 31, 2002 | -1.153 |
| July 31, 2002 | -1.210 |
| April 30, 2002 | -1.303 |
| January 31, 2002 | -1.415 |
| October 31, 2001 | -1.620 |
| July 31, 2001 | -1.765 |
| April 30, 2001 | -2.227 |
| January 31, 2001 | -2.524 |
| October 31, 2000 | -3.172 |
| July 31, 2000 | -3.789 |
| April 30, 2000 | -6.333 |
| January 31, 2000 | -5.518 |
| October 31, 1999 | -11.69 |
| July 31, 1999 | -15.50 |
| April 30, 1999 | 1.328 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 0.0628M |
| Total Liabilities (Quarterly) | 0.0845M |
| Shareholders Equity (Quarterly) | -0.0217M |